Prospective Observational Study to Assess Effectiveness and Safety of Intravenous Ferric Carboxymaltose 1000 mg in Patients of Chronic Heart Failure with Iron DeficiEncy - PRIDE-HF Study. ccm. 2023;7(6):349-354. Accessed September 17, 2026. https://fortunejournals.org/ojs/index.php/ccm/article/view/16439